<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04897360</url>
  </required_header>
  <id_info>
    <org_study_id>20-012481</org_study_id>
    <nct_id>NCT04897360</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Effects of Sharpened Romberg Testing (SRT) in Healthy Subjects</brief_title>
  <official_title>Effects of Hypocapnia on Postural Standing Balance Measured by Sharpened Romberg Testing (SRT) in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is being done to evaluate the effectiveness of using the sharpened&#xD;
      Romberg test to screen for impaired postural control in patients with impaired or altered&#xD;
      breathing patterns.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effects of hypocapnia on the postural system have not previously been adequately&#xD;
      investigated. The specific aim of this study is to evaluate the effects of hypocapnia on&#xD;
      postural standing balance using the sharpened Romberg test (SRT). There is very little&#xD;
      research in this area, even though there is significant clinical relevance, ranging from&#xD;
      individuals with conditions affecting ventilation (respiratory conditions, cardiac&#xD;
      conditions, concussions, medications, post-surgical states requiring ventilatory support&#xD;
      etc). The design of the experiment consists of testing healthy subjects and measuring their&#xD;
      standing balance with SRT before and after they deliberately lower their carbon dioxide&#xD;
      levels by increased ventilation over 2min. End-tidal CO2 (ETCO2) will be used to estimate the&#xD;
      blood carbon dioxide level during the experimental procedures. ETCO2 will be measured using&#xD;
      the Masimo, Emma Capnometer device. The device is a measurement tool that reads the end tidal&#xD;
      carbon dioxide level on its display. The results will then be compared to the normal&#xD;
      pre-hypocapnic SRT to assess how hypocapnia affects standing balance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">June 22, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 17, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to step out from sharpened Romberg test</measure>
    <time_frame>approximately 10min</time_frame>
    <description>measurement of time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Capnic status</measure>
    <time_frame>approximately 3 minutes</time_frame>
    <description>measurement of ETCO2 with capnometer</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hypocapnia</condition>
  <condition>Balance; Distorted</condition>
  <arm_group>
    <arm_group_label>Normocapnic SRT, Hypocapnic SRT, Recovery SRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sharpened Romberg Test</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Increased breathing</intervention_name>
    <description>hyperventilation to lower ETCO2</description>
    <arm_group_label>Normocapnic SRT, Hypocapnic SRT, Recovery SRT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sharpened Romberg test (SRT)</intervention_name>
    <description>Balance test conducted by standing with feet in front of each other, heel-to-toe in line while the right hand is on the left shoulder and the left hand is on the right shoulder.</description>
    <arm_group_label>Normocapnic SRT, Hypocapnic SRT, Recovery SRT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Research subject conditions that may result in alterations of ventilatory control (capnic&#xD;
        status) and balance will be specifically reviewed as criteria for participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current pregnancy in women, alcohol use within the past 3 days prior to the&#xD;
             experiment, history of balance problems (e.g., vertigo, neuropathy, central or&#xD;
             peripheral vestibular disorders), and musculoskeletal disorders affecting the ability&#xD;
             to perform a SRT in participants.&#xD;
&#xD;
          -  Patients currently taking carbonic anhydrase inhibitors, opioids, benzodiazepines,&#xD;
             hypnotics, first-generation H1 antihistamines, amphetamines, and first-generation&#xD;
             antipsychotics.&#xD;
&#xD;
          -  Patients with a history of insomnia, sleep apnea, circadian rhythm disturbances,&#xD;
             narcolepsy, movement disorders, chronic low blood pressure, fainting spells, multiple&#xD;
             concussions, seizure disorders, migraines, severe headaches and panic attacks.&#xD;
&#xD;
          -  If the patient took medications known to cause prolonged QTc interval and other&#xD;
             cardiac arrhythmias, the researchers will exclude the patient from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Stepanek, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jody Devine</last_name>
      <phone>480-301-6767</phone>
      <email>devine.jody@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Gaurav Pradhan, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Eboka</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 17, 2021</study_first_submitted>
  <study_first_submitted_qc>May 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Jan Stepanek</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>hypocapnia</keyword>
  <keyword>balance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypocapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

